Cerus (CERS) Non-Current Debt (2010 - 2026)
Cerus (CERS) reported Non-Current Debt of $32.4 million for Q1 2026, down 50.01% on a YoY basis from $64.9 million in Q1 2025, and down 20.0% sequentially from $40.5 million in Q4 2025.
Cerus (CERS) Non-Current Debt (2010 - 2026) Analysis & Trends
Cerus (CERS) has 17 years of Non-Current Debt data on file, last reported at $32.4 million in Q1 2026.
- For the quarter ending Q1 2026, Non-Current Debt fell 50.01% year-over-year to $32.4 million; the trailing twelve-month figure through Mar 2026 stood at $32.4 million (down 50.01% YoY), and the FY2025 full-year result was $40.5 million, down 37.49% from the prior year.
- Non-Current Debt retreated to $32.4 million in Q1 2026, from $40.5 million in the prior quarter.
- In the past five years, Non-Current Debt ranged from a high of $64.9 million in Q1 2025 to a low of $13.6 million in Q4 2022.
- A 5-year average of $51.1 million and a median of $54.8 million in 2023 frame the typical range for Non-Current Debt.
- Across the five-year window, Non-Current Debt plunged 75.07% in 2022 and soared 338.26% in 2023, its largest moves.
- Tracing CERS's Non-Current Debt over 5 years: stood at $13.6 million in 2022, then surged by 338.26% to $59.8 million in 2023, then advanced by 8.47% to $64.9 million in 2024, then slumped by 37.49% to $40.5 million in 2025, then dropped by 20.0% to $32.4 million in 2026.
- Business Quant data shows CERS's Non-Current Debt at $32.4 million in Q1 2026, $40.5 million in Q4 2025, and $48.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 29.64 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 14.22 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 26.17 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 10.99 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 598.50 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 10.13 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | 3.18 Bn |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 8.07 Bn |
| 10 | Cerus | 600.87 Mn | 520.44 Mn | 27.89 Mn | 32.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32.43 Mn |
| Dec 31, 2025 | 40.55 Mn |
| Sep 30, 2025 | 48.66 Mn |
| Jun 30, 2025 | 56.77 Mn |
| Mar 31, 2025 | 64.88 Mn |
| Dec 31, 2024 | 64.86 Mn |
| Sep 30, 2024 | 64.85 Mn |
| Jun 30, 2024 | 64.84 Mn |
| Mar 31, 2024 | 64.83 Mn |
| Dec 31, 2023 | 59.80 Mn |
| Sep 30, 2023 | 59.79 Mn |
| Jun 30, 2023 | 54.84 Mn |
| Mar 31, 2023 | 54.83 Mn |
| Dec 31, 2022 | 13.64 Mn |
| Sep 30, 2022 | 27.36 Mn |
| Jun 30, 2022 | 41.07 Mn |
| Mar 31, 2022 | 54.77 Mn |
| Dec 31, 2021 | 54.72 Mn |
| Sep 30, 2021 | 54.68 Mn |
| Jun 30, 2021 | 54.68 Mn |